A pill for our market access ills?

New initiatives and generic brands have reduced medicine costs for the state, but more needs to be done to improve patients’ access to new treatments

5th August, 2018
New medicines should be made available to patients in Ireland at far more sustainable prices Pic: Bloomberg

According to Atul Gawande, professor in the department of health policy and management at Harvard School of Public Health, our ever-changing world of modern medicine challenges us with 13,000 diseases, 6,000 drugs and 4,000 surgical procedures. The rapidly evolving world of medicine plays a crucial part in helping us fight sickness and disease. That is why we, as a society, should pay close attention to the approach our government, and the HSE, is taking towards...

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

Private rental sector remains strong despite Covid-19

How the programme for government will shape housing

Comment: US must defuse Covid-19’s ticking time bomb of debt

Comment: The recovery will be more U than V-shaped